Marianne Lewis, Ph.D., dean at the Carl H. Lindner College of Business is also excited by what the collaboration between Strawn and Mills will yield.
“Research impact is most powerful at the intersections — across fields, between theory and practice, beyond silos,” Lewis said. “The collaboration between Strawn in his innovative medical studies and Mills with his predictive analysis expertise will yield rigorous, actionable insights that can make a difference. They set a great example for the university overall.”
While current standard treatments are ineffective for a number of patients, Strawn said, a precision-medicine approach to treat anxiety and depressive disorders could alleviate needless suffering, said Dr. Andrew Filak, interim senior vice president for health affairs and dean of the UC College of Medicine.
“Collaborative research gets to the heart of innovation,” Filak said. “As physicians, we are always asking ourselves: what else can we do for patients? How else can we help and heal? By joining their different fields, Dr. Strawn and Dr. Mills are together opening the door to a brighter future for the millions of people suffering from anxiety and depressive disorders.”
And for Yung, supporting Strawn’s research is a way to transform his experience into an opportunity to improve the lives of others through philanthropy.
“It’s hard to explain what depression is unless somebody’s been through it,” Yung said. “But I wanted to help. I’m able to help. So, I wanted to help with something that would make depression less painful for people.”